Follow
Isaac Turner
Title
Cited by
Cited by
Year
De novo assembly and genotyping of variants using colored de Bruijn graphs
Z Iqbal, M Caccamo, I Turner, P Flicek, G McVean
Nature genetics 44 (2), 226-232, 2012
6952012
Stable recombination hotspots in birds
S Singhal, EM Leffler, K Sannareddy, I Turner, O Venn, DM Hooper, ...
Science 350 (6263), 928-932, 2015
2262015
Strong male bias drives germline mutation in chimpanzees
O Venn, I Turner, I Mathieson, N de Groot, R Bontrop, G McVean
Science 344 (6189), 1272-1275, 2014
1412014
Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline
E Giannoulatou, G McVean, IB Taylor, SJ McGowan, GJ Maher, Z Iqbal, ...
Proceedings of the National Academy of Sciences 110 (50), 20152-20157, 2013
602013
Integrating long-range connectivity information into de Bruijn graphs
I Turner, KV Garimella, Z Iqbal, G McVean
Bioinformatics 34 (15), 2556-2565, 2018
502018
High-throughput microbial population genomics using the Cortex variation assembler
Z Iqbal, I Turner, G McVean
Bioinformatics 29 (2), 275-276, 2013
482013
High frequency and prevalence of community-based asymptomatic SARS-CoV-2 infection
LT Allan-Blitz, I Turner, F Hertlein, JD Klausner
MedRxiv, 2020
92020
Mapping the drivers of within-host pathogen evolution using massive data sets
DS Palmer, I Turner, S Fidler, J Frater, D Goedhals, P Goulder, ...
Nature communications 10 (1), 1-14, 2019
52019
Association of lower socioeconomic status and SARS-CoV-2 positivity in Los Angeles, California
LT Allan-Blitz, C Goldbeck, F Hertlein, I Turner, JD Klausner
Journal of Preventive Medicine and Public Health 54 (3), 161, 2021
32021
Discovering genetic variation in populations using next generation sequencing and de novo assembly
IHC Turner
University of Oxford, 2018
22018
Heterogenous Exposures May Drive SARS-CoV-2 Positivity Among Different Subpopulations
LT Allan-Blitz, F Hertlein, I Turner, JD Klausner
Open Forum Infectious Diseases 8 (7), ofab183, 2021
12021
The Covid-19 Vaccine-Development Multiverse.
N Kojima, I Turner, JD Klausner
The New England Journal of Medicine 384 (7), 2021
12021
The Impact of Frequent SARS-CoV-2 Testing on Weekly Case Rates Among Long-Term Care Facilities in Florida
LT Allan-Blitz, B Aboabdo, I Turner, JD Klausner
medRxiv, 2022
2022
Characteristics of SARS‐CoV‐2 positive individuals in California from two periods during notable decline in incident infection
LT Allan‐Blitz, I Turner, F Hertlein, JD Klausner
Health Science Reports 4 (4), 2021
2021
The Rising Prevalence of SARS-CoV-2 Infection May Not be Due to Young Adults
LT Allan-Blitz, F Hertlein, I Turner, JD Klausner
The Pediatric Infectious Disease Journal 40 (5), e213-e214, 2021
2021
COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev (vol 11, pg 329, 2020)
F Turner, I Turner, V Slepnev
CELL SYSTEMS 11 (6), 663-663, 2020
2020
COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders
F Turner, I Turner, V Slepnev
Cell Systems 11, 329, 2020
2020
Understanding Specific Radiation Damage
M Gerstel, I Turner, C Deane, E Garman
2011
Characteristics of< scp> SARS‐CoV</scp>‐2 positive individuals in California from two periods during notable decline in incident infection
LT Allan‐Blitz, I Turner, F Hertlein, JD Klausner
The Covid-19 Vaccine-Development Multiverse| NEJM
N Kojima, I Turner, SD Curative, CAJD Klausner
The system can't perform the operation now. Try again later.
Articles 1–20